VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $697,000 | +45.8% | 30,000 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $478,000 | -23.3% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $623,000 | +44.9% | 30,000 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $430,000 | -17.1% | 30,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $519,000 | +56.8% | 30,000 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $331,000 | +2106.7% | 30,000 | +2900.0% | 0.00% | – |
| Q4 2016 | $15,000 | -97.2% | 1,000 | -95.1% | 0.00% | -100.0% |
| Q1 2016 | $537,000 | -68.9% | 20,404 | +20.1% | 0.00% | -66.7% |
| Q4 2015 | $1,727,000 | -16.8% | 16,988 | +46.0% | 0.01% | -18.2% |
| Q3 2015 | $2,075,000 | -11.2% | 11,632 | +10.5% | 0.01% | 0.0% |
| Q2 2015 | $2,338,000 | +11.8% | 10,526 | 0.0% | 0.01% | +22.2% |
| Q1 2015 | $2,091,000 | +6236.4% | 10,526 | +3948.5% | 0.01% | – |
| Q2 2014 | $33,000 | -2.9% | 260 | 0.0% | 0.00% | – |
| Q1 2014 | $34,000 | – | 260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |